SCHEMBL5787532

SCHEMBL5787532

NCCC1CCc2ccccc2N1

nearest known ligand 0.50

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 3/20 0.50
HTR2A P28223 3/20 0.43
HRH1 P35367 2/20 0.43
SMYD3 Q9H7B4 1/20 0.40
IDO1 P14902 1/20 0.39
RET P07949 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7951734 0.89 MTNR1A (0.55) MTNR1AHTR2ASMYD3RET
SCHEMBL18668694 0.87 MTNR1A (0.46) MTNR1AHTR2AHRH1SMYD3IDO1
SCHEMBL3972852 0.86 MTNR1A (0.52) MTNR1AHTR2AHRH1SMYD3RET
Hydrochloric Acid SCHEMBL6442427 0.84 MTNR1A (0.51) MTNR1AHTR2AHRH1SMYD3IDO1
SCHEMBL4728695 0.83 MTNR1A (0.50) MTNR1AHTR2ASMYD3
SCHEMBL4138599 0.83 MTNR1A (0.57) MTNR1ASMYD3
SCHEMBL7381467 0.82 HTR2A (0.46) HTR2AHRH1IDO1
SCHEMBL4138679 0.80 MTNR1A (0.48) MTNR1A
SCHEMBL4045997 0.80 MTNR1A (0.55) MTNR1ASMYD3
SCHEMBL4729455 0.80 MTNR1A (0.48) MTNR1AHTR2ASMYD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1633348-A1 4- BROMO - 5 - (2- CHLORO - BENZOYLAMINO) - 1H - PYRAZOLE - 3 - CARBOXYLIC ACID AMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ B sb 1 /sb RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES Elan Pharmaceuticals, Inc. (US) 2006-03-15 EP disclosed
WO-2004098589-A1 4- BROMO - 5 - (2- CHLORO - BENZOYLAMINO) - 1H - PYRAZOLE - 3 - CARBOXYLIC ACID AMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ B1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES ELAN PHARMACEUTICALS, INC. (US) 2004-11-18 WO disclosed